| Japanese Journal of Clinical Oncology | Pages |
Introducing `Cancer Genetics Report' as a New Section in JJCO: Dawn of Post-sequencing Age of Human Genome Project
Teruhiko Yoshida, Genetics Division, National Cancer Center Research Institute, Tokyo, Japan
The `Instructions to authors' of JJCO defines its scope as `original articles and case reports related to clinical research on cancer and allied fields.' So, where does `clinical' research end and `basic' research begin? The boundary between the two fields is increasingly blurred or even meaningless in some instances. This trend has been largely driven by the rapid advances in molecular genetics, which have revolutionized some of the fundamental concepts of carcinogenesis, and by the massive power of biotechnology. In parallel, more attention has been directed to the rational design of clinical protocol studies, and ELSI (ethical, legal and social issues) are now widely recognized as an integral part of pre-clinical as well as clinical medical research. We increasingly hear the